Integrative Korean medicine intervention incorporating angelica gigas for refractory chronic fibromyalgia: A clinical case report.

Researchers reported on a woman in her 50s who had suffered from fibromyalgia for 10 years without finding relief from conventional medications, including opioid painkillers. Fibromyalgia is a chronic condition affecting 2-4% of people worldwide, causing widespread body pain, fatigue, sleep problems, and difficulty concentrating due to how the central nervous system processes pain signals.

The patient had tried multiple treatments at different medical facilities but continued experiencing severe pain throughout her body, couldn't sleep due to nighttime pain, and struggled with daily activities. She had been using a buprenorphine pain patch long-term along with several oral pain medications.

During a 6-week inpatient stay, she received integrative Korean medicine treatments combining herbal medicine, acupuncture, pharmacopuncture (injecting herbal extracts at acupuncture points), Chuna manual therapy, and physical therapy. The treatment team identified a "blood stasis pattern" - possibly related to her prolonged painkiller use - as the underlying problem. The core herbal prescription featured high doses of Angelica gigas (Korean Danggui), an herb traditionally used to activate blood circulation.

After treatment, the patient showed measurable improvements in pain levels, quality of life, physical function, and joint mobility. Both standardized medical assessments and the patient's own reports confirmed these positive changes.

This case suggests that integrative Korean medicine approaches, particularly when incorporating blood-activating herbs like Angelica gigas, may offer hope for fibromyalgia patients who haven't responded to conventional treatments. While this represents only one patient's experience, the documented improvements across multiple measures are encouraging. If you're considering acupuncture or integrative treatments for fibromyalgia, seek a qualified, licensed practitioner experienced in treating chronic pain conditions.

This case report documents a 50-year-old female with treatment-refractory fibromyalgia of 10 years' duration who underwent 6 weeks of inpatient integrative Korean medicine therapy. The patient had failed multiple conventional pharmacological interventions including chronic opioid therapy (buprenorphine transdermal system) at multiple institutions.

Intervention consisted of herbal medicine, acupuncture, pharmacopuncture, Chuna manual therapy, and physical therapy. Pattern differentiation identified blood stasis as the primary pathomechanism, potentially linked to prolonged analgesic use. The therapeutic approach centered on blood-activating herbal formulation with high-dose Angelica gigas (Korean Danggui) as the principal ingredient.

Outcome measures demonstrated clinically significant improvements across multiple domains: pain intensity (NRS), quality of life (EQ-5D), and functional capacity (WOMAC, SPADI, ODI, NDI), along with objective improvements in joint range of motion. Sample size: n=1.

Clinical takeaway: Integrative Korean medicine with blood-activating botanicals may provide therapeutic benefit in opioid-refractory fibromyalgia, particularly when blood stasis pattern is identified. This case supports considering pattern-based herbal interventions as adjunctive therapy for complex chronic pain conditions unresponsive to conventional management.